terazosin
NDC 51655-915, terazosin, capsule, from Northwind Health Company, LLC.
- Product NDC
- 51655-915
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075614
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51655-915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51655-915-52 | 51655091552 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-915-52) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ff0efbc2-d7aa-9783-e053-6394a90a384f
Use it
Look up 51655-915 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51655-915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51655-915. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.